How much do Americans spend on GLP-1 medications? VCU medical students measure drug affordability
Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, Danish study suggests
GLP-1 receptor agonist coverage for obesity in Medicaid and total GLP-1 receptor agonist utilization
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
GLP-1 drugs fail to help some people lose weight — scientists are on a quest for answers
Should we use GLP-1 drugs to treat obesity in children?
RNA therapy may help preserve muscle during GLP-1 weight loss
GLP-1 use among young children with obesity in US remains rare but is rising rapidly
GLP-1 treatment late in life extends lifespan in animal model
GLP-1 weight-loss medication could slow aging and extend lifespan
Can GLP-1 drugs slow ageing? Mouse study shows promise
GLP-1 meds prompt rethink of obesity and eating disorder care
GLP-1 meds prompt rethink of obesity and eating disorder care
Researchers examine unanticipated benefits of GLP-1 medications - EurekAlert!
Do GLP-1 drugs like Ozempic prevent cancer? (Headlines suggest popular diabetes and weight-loss drugs prevent cancer, but epidemiologists warn that early observational data may be misleading.)
GLP-1 drugs linked to lower fracture risk in adults with type 2 diabetes - EurekAlert!
Marshall University researcher helps develop first international guidance on GLP-1 medications and women's reproductive health - EurekAlert!
Oral GLP-1 drugs may quiet the brain’s food craving circuit
GLP-1 diabetes drugs linked to increased risk of hair loss - EurekAlert!
Study finds no statistical link between use of semaglutide and other GLP-1 drugs and risk of degenerative eye disease in adults with type 2 diabetes - EurekAlert!
